Trueblood Wealth Management’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972K Sell
3,088
-1,311
-30% -$413K 0.34% 97
2026
Q1
$1.45M Sell
4,399
-193
-4% -$69.3K 0.57% 54
2025
Q4
$1.61M Hold
4,592
0.63% 45
2025
Q3
$1.7M Buy
4,592
+234
+5% +$90.4K 0.66% 35
2025
Q2
$1.72M Buy
4,358
+336
+8% +$126K 0.72% 32
2025
Q1
$1.5M Buy
4,022
+882
+28% +$336K 0.69% 37
2024
Q4
$1.13M Buy
3,140
+299
+11% +$111K 0.56% 53
2024
Q3
$1.03M Buy
2,841
+200
+8% +$69K 0.52% 61
2024
Q2
$899K Buy
2,641
+527
+25% +$179K 0.51% 62
2024
Q1
$757K Buy
2,114
+25
+1% +$8.41K 0.43% 74
2023
Q4
$626K Buy
+2,089
New +$586K 0.39% 84

Other funds holding SYK

Trueblood Wealth Management's SYK Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Stryker (SYK) stake by 30% in Q2 2026, selling an estimated $413K and leaving 3,088 shares worth $972K. The position accounts for 0.34% of the portfolio, ranked #97.

Trueblood Wealth Management first reported a position in SYK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.72M in Q2 2025. 842 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Trueblood Wealth Management held 3,088 shares of Stryker worth $972K as of Q2 2026.
  • Trueblood Wealth Management sold 1,311 Stryker shares in Q2 2026, an estimated $413K.
  • Stryker made up 0.34% of Trueblood Wealth Management's portfolio in Q2 2026, its #97 holding.
  • Trueblood Wealth Management first reported a position in Stryker in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Stryker position peaked at $1.72M in Q2 2025.
  • 842 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.